Decree Outlines Path to Move Forward on Manufacturing at Totowa Facilities

MORRISTOWN, N.J. -- Actavis Inc. today announced that it has reached agreement on a Consent Decree of Permanent Injunction with the Food and Drug Administration (FDA) regarding the company's Actavis Totowa LLC subsidiary. This agreement, in effect, settles the issues identified by the Department of Justice in its previously filed complaint against Actavis Inc., Actavis Totowa, and officers Sigurdur Oli Olafsson and Douglas Boothe.

The Consent Decree only affects operations at Actavis ...

Find more facts and information related to the article "Actavis Totowa and FDA Reach Agreement on Consent ..."